Finance

Lists
002275:SHE
Guilin Sanjin Pharmaceutical Co., Ltd.
CN¥12.25
-0.65%
(-0.080) 1D
Oct 13, 3:04:18 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002275...
Open
CN¥12.31
High
CN¥12.31
Low
CN¥12.19
Mkt. cap
7.24B
Avg. vol.
2.12M
Volume
1.21M
Dividend
4.08%
Quarterly dividend
CN¥0.12
Ex-dividend date
Jun 4, 2026
P/E ratio
17.69
52-wk high
CN¥15.75
52-wk low
CN¥11.91
EPS
CN¥0.69
Shares outstanding
587.57M
No. of employees
3K
Open
CN¥12.31
High
CN¥12.31
Low
CN¥12.19
Mkt. cap
7.24B
Avg. vol.
2.12M
Volume
1.21M
Dividend
4.08%
Quarterly dividend
CN¥0.12
Ex-dividend date
Jun 4, 2026
P/E ratio
17.69
52-wk high
CN¥15.75
52-wk low
CN¥11.91
EPS
CN¥0.69
Shares outstanding
587.57M
No. of employees
3K
News stories
From web sources and news partners
About Guilin Sanjin Pharmaceutical Co., Ltd.
CEO-
Employees2.56K
FoundedFeb 23, 1994
Headquarters-
SectorPharmaceutical industry
Websitesanjin.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
464.04M
583.35M
525.12M
443.48M
Cost of goods sold
120.09M
146.29M
93.13M
145.58M
Cost of revenue
120.09M
146.29M
93.13M
145.58M
Research and development expenses
30.18M
68.98M
53.24M
10.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
193.59M
270.13M
185.28M
122.37M
Operating expense
231.97M
354.02M
284.20M
152.34M
Total operating expenses
352.07M
500.30M
377.33M
297.92M
Operating income
111.98M
83.04M
147.79M
145.56M
Other non operating income
-1.66M
1.46M
-151.83K
-496.00
EBT including unusual items
127.69M
67.38M
152.08M
161.91M
EBT excluding unusual items
116.86M
74.31M
150.90M
149.82M
Income tax expense
29.29M
19.47M
27.73M
25.60M
Effective tax rate
22.94%
28.90%
18.23%
15.81%
Other operating expenses
6.24M
1.60M
1.07M
15.00M
Net income
98.40M
47.91M
124.36M
136.31M
Net profit margin
21.21%
8.21%
23.68%
30.74%
Earnings per share
-
-
-
-
Interest and investment income
8.43M
6.17M
4.23M
9.11M
Interest expense
-1.89M
-16.71M
-971.70K
-4.93M
Net interest expenses
6.53M
-10.54M
3.26M
4.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
134.72M
103.95M
168.69M
166.41M
Gain or loss from assets sale
1.86K
-145.62K
-
-8.06K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps